These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15044316)

  • 1. Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development.
    Choy WY; Lin SG; Chan PK; Tam JS; Lo YM; Chu IM; Tsai SN; Zhong MQ; Fung KP; Waye MM; Tsui SK; Ng KO; Shan ZX; Yang M; Wu YL; Lin ZY; Ngai SM
    Clin Chem; 2004 Jun; 50(6):1036-42. PubMed ID: 15044316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
    J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two antigenic epitopes on SARS-CoV spike protein.
    Hua R; Zhou Y; Wang Y; Hua Y; Tong G
    Biochem Biophys Res Commun; 2004 Jul; 319(3):929-35. PubMed ID: 15184071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.
    He Y; Zhou Y; Wu H; Luo B; Chen J; Li W; Jiang S
    J Immunol; 2004 Sep; 173(6):4050-7. PubMed ID: 15356154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.
    Tsao YP; Lin JY; Jan JT; Leng CH; Chu CC; Yang YC; Chen SL
    Biochem Biophys Res Commun; 2006 May; 344(1):63-71. PubMed ID: 16630549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.
    Liu RY; Wu LZ; Huang BJ; Huang JL; Zhang YL; Ke ML; Wang JM; Tan WP; Zhang RH; Chen HK; Zeng YX; Huang W
    Virus Res; 2005 Sep; 112(1-2):24-31. PubMed ID: 16022898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).
    Lai SC; Chong PC; Yeh CT; Liu LS; Jan JT; Chi HY; Liu HW; Chen A; Wang YC
    J Biomed Sci; 2005 Oct; 12(5):711-27. PubMed ID: 16132115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
    Chen Z; Zhang L; Qin C; Ba L; Yi CE; Zhang F; Wei Q; He T; Yu W; Yu J; Gao H; Tu X; Gettie A; Farzan M; Yuen KY; Ho DD
    J Virol; 2005 Mar; 79(5):2678-88. PubMed ID: 15708987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice.
    Lee JS; Poo H; Han DP; Hong SP; Kim K; Cho MW; Kim E; Sung MH; Kim CJ
    J Virol; 2006 Apr; 80(8):4079-87. PubMed ID: 16571824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice.
    Zhou Z; Post P; Chubet R; Holtz K; McPherson C; Petric M; Cox M
    Vaccine; 2006 Apr; 24(17):3624-31. PubMed ID: 16497416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
    He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S
    Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants.
    Deming D; Sheahan T; Heise M; Yount B; Davis N; Sims A; Suthar M; Harkema J; Whitmore A; Pickles R; West A; Donaldson E; Curtis K; Johnston R; Baric R
    PLoS Med; 2006 Dec; 3(12):e525. PubMed ID: 17194199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
    Zhi Y; Kobinger GP; Jordan H; Suchma K; Weiss SR; Shen H; Schumer G; Gao G; Boyer JL; Crystal RG; Wilson JM
    Virology; 2005 Apr; 335(1):34-45. PubMed ID: 15823604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
    Zhou T; Wang H; Luo D; Rowe T; Wang Z; Hogan RJ; Qiu S; Bunzel RJ; Huang G; Mishra V; Voss TG; Kimberly R; Luo M
    J Virol; 2004 Jul; 78(13):7217-26. PubMed ID: 15194798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
    Hu H; Lu X; Tao L; Bai B; Zhang Z; Chen Y; Zheng F; Chen J; Chen Z; Wang H
    Clin Vaccine Immunol; 2007 Jul; 14(7):894-901. PubMed ID: 17494640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Chou TH; Wang S; Sakhatskyy PV; Mboudjeka I; Lawrence JM; Huang S; Coley S; Yang B; Li J; Zhu Q; Lu S
    Virology; 2005 Mar; 334(1):134-43. PubMed ID: 15749129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
    He Y; Li J; Heck S; Lustigman S; Jiang S
    J Virol; 2006 Jun; 80(12):5757-67. PubMed ID: 16731915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.
    Wang YD; Sin WY; Xu GB; Yang HH; Wong TY; Pang XW; He XY; Zhang HG; Ng JN; Cheng CS; Yu J; Meng L; Yang RF; Lai ST; Guo ZH; Xie Y; Chen WF
    J Virol; 2004 Jun; 78(11):5612-8. PubMed ID: 15140958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.